- Home
- TTNP vs CPHI Comparison
TTNP vs CPHI Comparison
Compare TTNP & CPHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- TTNP
- CPHI
- Stock Information
- Founded
- TTNP 1991
- CPHI N/A
- Country
- TTNP United States
- CPHI China
- Employees
- TTNP N/A
- CPHI N/A
- Industry
- TTNP Biotechnology: Biological Products (No Diagnostic Substances)
- CPHI Biotechnology: Pharmaceutical Preparations
- Sector
- TTNP Health Care
- CPHI Health Care
- Exchange
- TTNP Nasdaq
- CPHI Nasdaq
- Market Cap
- TTNP 5.4M
- CPHI 5.5M
- IPO Year
- TTNP 1996
- CPHI N/A
- Fundamental
- Price
- TTNP $4.38
- CPHI $1.83
- Analyst Decision
- TTNP
- CPHI
- Analyst Count
- TTNP 0
- CPHI 0
- Target Price
- TTNP N/A
- CPHI N/A
- AVG Volume (30 Days)
- TTNP 17.4K
- CPHI 87.8K
- Earning Date
- TTNP 08-14-2025
- CPHI 08-13-2025
- Dividend Yield
- TTNP N/A
- CPHI N/A
- EPS Growth
- TTNP N/A
- CPHI N/A
- EPS
- TTNP N/A
- CPHI N/A
- Revenue
- TTNP N/A
- CPHI $4,295,377.00
- Revenue This Year
- TTNP N/A
- CPHI N/A
- Revenue Next Year
- TTNP N/A
- CPHI N/A
- P/E Ratio
- TTNP N/A
- CPHI N/A
- Revenue Growth
- TTNP N/A
- CPHI N/A
- 52 Week Low
- TTNP $3.03
- CPHI $1.20
- 52 Week High
- TTNP $14.80
- CPHI $3.35
- Technical
- Relative Strength Index (RSI)
- TTNP 47.75
- CPHI 51.50
- Support Level
- TTNP $3.82
- CPHI $1.77
- Resistance Level
- TTNP $5.35
- CPHI $1.93
- Average True Range (ATR)
- TTNP 0.42
- CPHI 0.14
- MACD
- TTNP -0.01
- CPHI 0.01
- Stochastic Oscillator
- TTNP 36.60
- CPHI 65.63
About TTNP Titan Pharmaceuticals Inc.
Titan Pharmaceuticals Inc is a development stage company developing proprietary therapeutics with utilizing ProNeura long-term, continuous drug delivery technology. The ProNeura technology has the potential to be used in developing products for treating a number of chronic conditions, where maintaining consistent, around-the-clock blood levels of medication may benefit the patient and improve medical outcomes.
About CPHI China Pharma Holdings Inc.
China Pharma Holding Inc is a drug manufacturing company. It is mainly engaged in the development, manufacture, and marketing of pharmaceutical products for human use in connection with a variety of high-incidence and high-mortality diseases and medical conditions prevalent in the People's Republic of China. The company mainly manufactures pharmaceutical products in the form of dry powder injectables, liquid injectables, tablets, capsules, and cephalosporin oral solutions. The product line of the company includes cefaclor dispersible tablets, clarithromycin granules, roxithromycin dispersible tablets, andrographolide tablets, ozagrel sodium for injection, gastrodin injection and others.